Crescent Biopharma (C68.STU) Q2 2026 Earnings

30AprConfirmed
Q1 2026
Next
-3.4
-2.52
-1.63
-0.75

Details

Expected EPS
-0.75190741893
Actual EPS
N/A
Surprise EPS
0.75
Surprise Percent
+100%

Description

Crescent Biopharma (C68.STU) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts